CSL acquires majority stake in Chinese plasma manufacturer Ruide for $352mm, plus earn-out
- Synthesis Technologies, Production Processes
- Includes Earnout
- Acquisition of Private Biotech
- Payment Includes Cash
- Partial Acquisition
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.